Invesco Biotechnology & Genome ETF (PBE)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn morePerformance Overview
Trailing returns as of 10/31/2026. Category is Health.
YTD Return
1-Year Return
3-Year Return
Trailing Returns (%) Vs. Benchmarks
- YTD
- 19.60%
- -2.39%
- 1-Month
- 0.55%
- 1.70%
- 3-Month
- 8.38%
- -3.03%
- 1-Year
- 41.37%
- 21.31%
- 3-Year
- 20.28%
- 6.58%
- 5-Year
- 5.85%
- 1.49%
- 10-Year
- 9.11%
- 8.56%
- Last Bull Market
- 0.00%
- 0.00%
- Last Bear Market
- 0.00%
- 0.00%
Annual Total Return (%) History
ETF Summary
Under normal circumstances, at least 80% of the value of its net assets, plus the amount of any borrowings for investment purposes, in securities of companies engaged in biotechnology- and genome-related industries, and in derivatives and other investments that have economic characteristics similar to securities of companies engaged in biotechnology- and genome-related industries (the “80% investment policy”). It is non-diversified.
ETF Overview
| Category | Health |
|---|---|
| Fund Family | Invesco |
| Net Assets | 423.52M |
| YTD Daily Total Return | 26.13% |
| Yield | 1.37% |
| Legal Type | Exchange Traded Fund |
